돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1664086생성일: 2026년 10월 23일

Adipic Dihydrazide → Amikacin

https://huagongshe.com/ko/reaction/1664086

반응식

참여 물질

역할이름HCID투입량
반응물Adipic DihydrazideHCID 66117—
반응물Amikacin Sulfate SaltHCID 5458175—
반응물(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol sulfateHCID 86619106—
반응물(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide sulfateHCID 86619108—
반응물tobramycin sulfate clindamycin HClHCID 131729235—
생성물AmikacinHCID 37768—

반응 단계

Amikacin Sulfate (100 mg), DBM (200 mg), and 8 mg of adipic acid dihydrazide were placed into a beaker and mixed thoroughly. Oxidized dextran solution (Mw, 500,000; 66 mg/ml; 1 ml) was added to the mixture. Tobramycin-sulfate or tobramycin-sulfate/clindamycin-HCl (1/1) can be used in place of amikacin-sulfate.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08039021B2
출처 데이터셋uspto-grants-2011_10
ORD IDord-f1c377f4273646c9a4a40597dec3cc2f
출처 메모uspto-grants-2011_10